These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17674486)

  • 1. Loss-of-function genetic diseases and the concept of pharmaceutical targets.
    Ségalat L
    Orphanet J Rare Dis; 2007; 2():30. PubMed ID: 17674486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targetability of human disease genes.
    Sakharkar MK; Sakharkar KR
    Curr Drug Discov Technol; 2007 Jun; 4(1):48-58. PubMed ID: 17630928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics in drug discovery and development: challenge and promise of individualizing treatment in common complex diseases.
    Lindpaintner K
    Br Med Bull; 1999; 55(2):471-91. PubMed ID: 10723870
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics in drug development.
    McCarthy AD; Kennedy JL; Middleton LT
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding chemical drugs for genetic diseases.
    Sun HY; Hou TJ; Zhang HY
    Drug Discov Today; 2014 Dec; 19(12):1836-40. PubMed ID: 25256778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics.
    Vesell ES
    Biochem Pharmacol; 1975 Feb; 24(4):445-50. PubMed ID: 1167457
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenomic considerations in drug delivery.
    Attar M; Lee VH
    Pharmacogenomics; 2003 Jul; 4(4):443-61. PubMed ID: 12831323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems approaches for pharmacogenetics and pharmacogenomics.
    Bader JS
    Pharmacogenomics; 2008 Mar; 9(3):257-62. PubMed ID: 18303961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacogenetics: forerunner for individualized medicine].
    Lindpaintner K
    Ther Umsch; 2003 Aug; 60(8):487-92. PubMed ID: 14502858
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome-wide association studies of therapeutic response: addressing the complexities.
    Barrett JH
    Pharmacogenomics; 2019 Mar; 20(4):213-216. PubMed ID: 30767725
    [No Abstract]   [Full Text] [Related]  

  • 11. Human monogenic disorders - a source of novel drug targets.
    Brinkman RR; Dubé MP; Rouleau GA; Orr AC; Samuels ME
    Nat Rev Genet; 2006 Apr; 7(4):249-60. PubMed ID: 16534513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma pharmacogenomics.
    Hawkins GA; Weiss ST; Bleecker ER
    Immunol Allergy Clin North Am; 2005 Nov; 25(4):723-42. PubMed ID: 16257635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental and pediatric pharmacogenomics.
    Leeder JS
    Pharmacogenomics; 2003 May; 4(3):331-41. PubMed ID: 12718723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of pharmacogenetics.
    Katz DA
    Curr Protoc Hum Genet; 2006 May; Chapter 9():Unit 9.19. PubMed ID: 18428399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel methods for detecting epistasis in pharmacogenomics studies.
    Motsinger AA; Ritchie MD; Reif DM
    Pharmacogenomics; 2007 Sep; 8(9):1229-41. PubMed ID: 17924838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of clinical efficacy.
    Michelson S; Sehgal A; Friedrich C
    Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy.
    Zingman LV; Park S; Olson TM; Alekseev AE; Terzic A
    Clin Pharmacol Ther; 2007 Jan; 81(1):99-103. PubMed ID: 17186006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of genomics on anti-infectives drug discovery and development.
    Parkinson T
    Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Richard Weinshilboum: Pharmacogenetics: The future is here!
    Weinshilboum R
    Mol Interv; 2003 May; 3(3):118-22. PubMed ID: 14993417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities for developing therapies for rare genetic diseases: focus on gain-of-function and allostery.
    Chen B; Altman RB
    Orphanet J Rare Dis; 2017 Apr; 12(1):61. PubMed ID: 28412959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.